TNF Pharmaceuticals
  • Contact TNF
  • About Us
    • Team
  • Pipeline
    • MYMD-1®
    • Supera-CBD
  • Research
    • Clinical Trials
  • Investors
  • News
    • TNF News
    • Press Releases
    • Thought leadership
    • Perspectives
  • Subscribe
  • Contact TNF

Governance Documents

Investors

Investors

  • Overview
  • News & Events
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Management Team
    • Presentations
    • Contacts
    • FAQ
  • Financial Info
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Board of Directors
    • Board Committees
    • Governance Documents
    • Board Diversity Matrix
  • Governance

  • Board of Directors
  • Board Committees
  • Governance Documents
  • Board Diversity Matrix

Audit Committee Charter

Download Audit Committee Charter

Compensation Committee Charter

Download Compensation Committee Charter

Nominating and Corporate Governance Commitee Charter

Download Nominating and Corporate Governance Commitee Charter

Risk and Disclosure Committee

Download Risk and Disclosure Committee

Code Ethics

Download Code Ethics

Whistleblower Policy

Download Whistleblower Policy
  • Email Alerts
  • Contacts
  • RSS News Feed

Connect with TNF Pharmaceuticals

Subscribe to stay up-to-date on new developments.

Contact Us

TNF Pharmaceuticals

© 2025 TNF Pharmaceuticals™. All Right Reserved

  • Privacy Policy
  • Terms & Conditions

This site is not intended to provide medical advice or to suggest that any product mentioned is safe or efficacious for any disease or condition.

News & Resources

View a collection of articles, thought leadership content and industry news.

Subscribe to receive TNF announcements
  • This field is for validation purposes and should be left unchanged.